# Magnera Corp: financial statements, quarterly

MAGN · NYSE · CIK 41719 · [Materials](/sectors/materials.md) · fiscal year ends Sep 26

Pages: [Overview](/companies/magn.md) · [Financials](/companies/magn/financials.md) · [Filings](/companies/magn/filings.md) · [Insiders](/companies/magn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/magn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [330](/filings/0000041719-24-000036.md) | [519](/filings/0000041719-25-000016.md) | [558](/filings/0000041719-25-000028.md) | [556](/filings/0001140361-25-029147.md) | [332](/filings/0000041719-24-000036.md) | [702](/filings/0000041719-26-000014.md) | [824](/filings/0000041719-26-000042.md) | [839](/filings/0000041719-26-000049.md) | [839 d](/filings/0000041719-25-000110.md) | [792](/filings/0000041719-26-000014.md) | [796](/filings/0000041719-26-000042.md) | [857](/filings/0000041719-26-000049.md) |
| Cost of revenue | $m | [285](/filings/0000041719-24-000036.md) | [477](/filings/0000041719-25-000016.md) | [488](/filings/0000041719-25-000028.md) | [489](/filings/0001140361-25-029147.md) | [297](/filings/0000041719-24-000036.md) | [631](/filings/0000041719-26-000014.md) | [736](/filings/0000041719-26-000042.md) | [749](/filings/0000041719-26-000049.md) | [751 d](/filings/0000041719-25-000110.md) | [695](/filings/0000041719-26-000014.md) | [701](/filings/0000041719-26-000042.md) | [745](/filings/0000041719-26-000049.md) |
| Gross profit | $m | [44.5](/filings/0000041719-24-000036.md) | [30.9 d](/filings/0000041719-24-000007.md) | [34.5](/filings/0000041719-24-000018.md) | [36.8](/filings/0000041719-24-000032.md) | [35.5](/filings/0000041719-24-000036.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [24.7](/filings/0000041719-24-000036.md) | [28.0](/filings/0000041719-25-000016.md) | [28.0](/filings/0000041719-25-000028.md) | [26.0](/filings/0001140361-25-029147.md) | [32.5](/filings/0000041719-24-000036.md) | [47.0](/filings/0000041719-26-000014.md) | [47.0](/filings/0000041719-26-000042.md) | [50.0](/filings/0000041719-26-000049.md) | [46.0 d](/filings/0000041719-25-000110.md) | [50.0](/filings/0000041719-26-000014.md) | [50.0](/filings/0000041719-26-000042.md) | [56.0](/filings/0000041719-26-000049.md) |
| Operating income | $m | [2.7](/filings/0000041719-24-000036.md) | [(12.0)](/filings/0000041719-25-000016.md) | [21.0](/filings/0000041719-25-000028.md) | [17.0](/filings/0001140361-25-029147.md) | [3.0](/filings/0000041719-24-000036.md) | [(22.0)](/filings/0000041719-26-000014.md) | [4.0](/filings/0000041719-26-000042.md) | [13.0](/filings/0000041719-26-000049.md) | [10.0 d](/filings/0000041719-25-000110.md) | [14.0](/filings/0000041719-26-000014.md) | [17.0](/filings/0000041719-26-000042.md) | [22.0](/filings/0000041719-26-000049.md) |
| Interest expense | $m | [17.4](/filings/0000041719-23-000048.md) | [0.0](/filings/0000041719-25-000016.md) | [2.0](/filings/0000041719-25-000028.md) | [1.0](/filings/0001140361-25-029147.md) | [18.4](/filings/0000041719-24-000036.md) | [26.0](/filings/0000041719-26-000014.md) | [39.0](/filings/0000041719-26-000042.md) | [37.0](/filings/0000041719-26-000049.md) | [39.0 d](/filings/0000041719-25-000110.md) | [40.0](/filings/0000041719-26-000014.md) | [35.0](/filings/0000041719-26-000042.md) | [37.0](/filings/0000041719-26-000049.md) |
| Income tax | $m | [3.3](/filings/0000041719-24-000036.md) | [(2.0)](/filings/0000041719-25-000016.md) | [4.0](/filings/0000041719-25-000028.md) | [(3.0)](/filings/0001140361-25-029147.md) | [1.5](/filings/0000041719-24-000036.md) | [(9.0)](/filings/0000041719-26-000014.md) | [1.0](/filings/0000041719-26-000042.md) | [(6.0)](/filings/0000041719-26-000049.md) | [7.0 d](/filings/0000041719-25-000110.md) | [5.0](/filings/0000041719-26-000014.md) | [1.0](/filings/0000041719-26-000042.md) | [2.0](/filings/0000041719-26-000049.md) |
| Net income | $m | [(19.9)](/filings/0000041719-24-000036.md) | [(8.0)](/filings/0000041719-25-000016.md) | [14.0](/filings/0000041719-25-000028.md) | [19.0](/filings/0001140361-25-029147.md) | [(15.2)](/filings/0000041719-24-000036.md) | [(60.0)](/filings/0000041719-26-000014.md) | [(41.0)](/filings/0000041719-26-000042.md) | [(18.0)](/filings/0000041719-26-000049.md) | [(40.0) d](/filings/0000041719-25-000110.md) | [(34.0)](/filings/0000041719-26-000014.md) | [(18.0)](/filings/0000041719-26-000042.md) | [(20.0)](/filings/0000041719-26-000049.md) |
| Diluted EPS | $ per share | [(0.43)](/filings/0000041719-24-000036.md) | [(0.25)](/filings/0000041719-25-000016.md) | [0.44](/filings/0000041719-25-000028.md) | [0.60](/filings/0001140361-25-029147.md) | [(0.33)](/filings/0000041719-24-000036.md) | [(1.69)](/filings/0000041719-26-000014.md) | [(1.15)](/filings/0000041719-26-000042.md) | [(0.51)](/filings/0000041719-26-000049.md) | not reported | [(0.95)](/filings/0000041719-26-000014.md) | [(0.50)](/filings/0000041719-26-000042.md) | [(0.56)](/filings/0000041719-26-000049.md) |
| Basic EPS | $ per share | [(0.43)](/filings/0000041719-24-000036.md) | [(0.25)](/filings/0000041719-25-000016.md) | [0.44](/filings/0000041719-25-000028.md) | [0.60](/filings/0001140361-25-029147.md) | [(0.33)](/filings/0000041719-24-000036.md) | [(1.69)](/filings/0000041719-26-000014.md) | [(1.15)](/filings/0000041719-26-000042.md) | [(0.51)](/filings/0000041719-26-000049.md) | not reported | [(0.95)](/filings/0000041719-26-000014.md) | [(0.50)](/filings/0000041719-26-000042.md) | [(0.56)](/filings/0000041719-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [52.7](/filings/0000041719-23-000048.md) | [50.3](/filings/0000041719-24-000036.md) | [30.2](/filings/0000041719-24-000018.md) | [33.9](/filings/0000041719-24-000032.md) | [230](/filings/0000041719-25-000110.md) | [215](/filings/0000041719-25-000016.md) | [282](/filings/0000041719-25-000028.md) | [276](/filings/0001140361-25-029147.md) | [305](/filings/0000041719-26-000049.md) | [264](/filings/0000041719-26-000014.md) | [303](/filings/0000041719-26-000042.md) | [280](/filings/0000041719-26-000049.md) |
| Current assets | $m | [595](/filings/0000041719-23-000048.md) | [606](/filings/0000041719-24-000036.md) | [584](/filings/0000041719-24-000018.md) | [586](/filings/0000041719-24-000032.md) | [886](/filings/0000041719-25-000110.md) | [1,338](/filings/0000041719-25-000016.md) | [1,428](/filings/0000041719-25-000028.md) | [1,484](/filings/0001140361-25-029147.md) | [1,423](/filings/0000041719-26-000049.md) | [1,365](/filings/0000041719-26-000014.md) | [1,407](/filings/0000041719-26-000042.md) | [1,392](/filings/0000041719-26-000049.md) |
| Total assets | $m | [1,533](/filings/0000041719-23-000048.md) | [1,564](/filings/0000041719-24-000036.md) | [1,517](/filings/0000041719-24-000018.md) | [1,505](/filings/0000041719-24-000032.md) | [2,807](/filings/0000041719-25-000110.md) | [3,993](/filings/0000041719-25-000016.md) | [4,061](/filings/0000041719-25-000028.md) | [4,112](/filings/0001140361-25-029147.md) | [3,989](/filings/0000041719-26-000049.md) | [3,893](/filings/0000041719-26-000014.md) | [3,896](/filings/0000041719-26-000042.md) | [3,834](/filings/0000041719-26-000049.md) |
| Current liabilities | $m | [256](/filings/0000041719-23-000048.md) | [280](/filings/0000041719-24-000036.md) | [253](/filings/0000041719-24-000018.md) | [265](/filings/0000041719-24-000032.md) | [457](/filings/0000041719-25-000110.md) | [546](/filings/0000041719-25-000016.md) | [596](/filings/0000041719-25-000028.md) | [584](/filings/0001140361-25-029147.md) | [601](/filings/0000041719-26-000049.md) | [556](/filings/0000041719-26-000014.md) | [605](/filings/0000041719-26-000042.md) | [569](/filings/0000041719-26-000049.md) |
| Total liabilities | $m | [1,279](/filings/0000041719-23-000048.md) | [1,307](/filings/0000041719-24-000036.md) | [1,294](/filings/0000041719-24-000018.md) | [1,300](/filings/0000041719-24-000032.md) | [668](/filings/0000041719-25-000110.md) | [2,887](/filings/0000041719-25-000016.md) | [2,968](/filings/0000041719-25-000028.md) | [2,981](/filings/0001140361-25-029147.md) | [2,925](/filings/0000041719-26-000049.md) | [2,855](/filings/0000041719-26-000014.md) | [2,857](/filings/0000041719-26-000042.md) | [2,817](/filings/0000041719-26-000049.md) |
| Long-term debt | $m | [848](/filings/0000041719-23-000048.md) | [853](/filings/0000041719-24-000036.md) | [868](/filings/0000041719-24-000018.md) | [862](/filings/0000041719-24-000032.md) | [0.0](/filings/0000041719-25-000110.md) | [1,988](/filings/0000041719-25-000016.md) | [1,990](/filings/0000041719-25-000028.md) | [1,991](/filings/0001140361-25-029147.md) | [1,952](/filings/0000041719-26-000049.md) | [1,931](/filings/0000041719-26-000014.md) | [1,899](/filings/0000041719-26-000042.md) | [1,901](/filings/0000041719-26-000049.md) |
| Current portion of debt | $m | [1.9](/filings/0000041719-23-000048.md) | [1.0](/filings/0000041719-24-000036.md) | [0.0](/filings/0000041719-24-000018.md) | [0.0](/filings/0000041719-24-000032.md) | [0.0](/filings/0001140361-25-029147.md) | [8.0](/filings/0000041719-25-000016.md) | [8.0](/filings/0000041719-25-000028.md) | [8.0](/filings/0001140361-25-029147.md) | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [5.6](/filings/0000041719-23-000048.md) | [6.2](/filings/0000041719-24-000036.md) | [7.5](/filings/0000041719-24-000018.md) | [8.5](/filings/0000041719-24-000032.md) | [7.6](/filings/0000041719-24-000036.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,390](/filings/0001140361-25-029147.md) | [2,416](/filings/0000041719-25-000028.md) | [2,430](/filings/0001140361-25-029147.md) | [2,394](/filings/0001140361-25-029147.md) | [2,139](/filings/0000041719-25-000110.md) | [1,106](/filings/0000041719-26-000014.md) | [1,093](/filings/0001140361-25-029147.md) | [1,131](/filings/0001140361-25-029147.md) | [1,064](/filings/0000041719-26-000049.md) | [1,038](/filings/0000041719-26-000014.md) | [1,039](/filings/0000041719-26-000042.md) | [1,017](/filings/0000041719-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.1 d](/filings/0000041719-24-000036.md) | [(27.0)](/filings/0000041719-25-000016.md) | [(33.5)](/filings/0000041719-24-000018.md) | [38.0 d](/filings/0001140361-25-029147.md) | [161 d](/filings/0000041719-25-000110.md) | [(58.0)](/filings/0000041719-26-000014.md) | [65.0 d](/filings/0000041719-26-000042.md) | [0.0 d](/filings/0000041719-26-000049.md) | [96.0 d](/filings/0000041719-25-000110.md) | [2.0](/filings/0000041719-26-000014.md) | [87.0 d](/filings/0000041719-26-000042.md) | [(13.0) d](/filings/0000041719-26-000049.md) |
| Capital expenditure | $m | [7.8](/filings/0000041719-24-000036.md) | [16.0](/filings/0000041719-25-000016.md) | [7.5](/filings/0000041719-24-000018.md) | [5.7](/filings/0000041719-24-000032.md) | [8.5](/filings/0000041719-24-000036.md) | [16.0](/filings/0000041719-26-000014.md) | [23.0 d](/filings/0000041719-26-000042.md) | [13.0 d](/filings/0000041719-26-000049.md) | [15.0 d](/filings/0000041719-25-000110.md) | [15.0](/filings/0000041719-26-000014.md) | [14.0 d](/filings/0000041719-26-000042.md) | [15.0 d](/filings/0000041719-26-000049.md) |
| Dividends paid | $m | [0.0 d](/filings/0000041719-23-000048.md) | [0.0 d](/filings/0000041719-24-000007.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.0](/filings/0000041719-24-000032.md) | [45.1](/filings/0000041719-24-000036.md) | [31.8](/filings/0000041719-25-000016.md) | [31.8](/filings/0000041719-25-000028.md) | [31.8](/filings/0001140361-25-029147.md) | [45.4](/filings/0000041719-24-000036.md) | [35.4](/filings/0000041719-26-000014.md) | [35.6](/filings/0000041719-26-000042.md) | [35.6](/filings/0000041719-26-000049.md) | [35.7](/filings/0000041719-26-000014.md) | [35.9](/filings/0000041719-26-000042.md) | [35.9](/filings/0000041719-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,800,000 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0000041719-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.